Assessment of mucociliary clearance as an indicator of nasal function in patients with COVID-19: a cross-sectional study

Eur Arch Otorhinolaryngol. 2021 Jun;278(6):1863-1868. doi: 10.1007/s00405-020-06457-y. Epub 2020 Nov 13.

Abstract

Purpose: We assessed the effects of COVID-19 infection on nasal mucociliary activity.

Methods: The study was conducted in the pandemic wards of Adiyaman University Training and Research Hospital during April and May 2020. All patients admitted to the COVID-19 pandemic wards during the study period were invited to participate in the study. The study included 40 adults who agreed to participate and underwent a mucociliary clearance test successfully. The primary outcome was mucociliary clearance time and the secondary variables of interest were age, sex, and sino-nasal outcome test-22 scores. The control group included 40 concomitant healthy patients who visited the outpatient ear, nose and throat clinic with non-nasal symptoms.

Results: The study included 40 COVID-19-positive patients and 40 healthy controls. The mean mucociliary clearance times of the study (15.53 ± 5.57 min) and control (9.50 ± 3.70 min) groups were significantly different (Z = 4.675, p < 0.001). However, the mucociliary clearance time was not significantly different between males and females (t = 0.590, p = 0.558).

Conclusions: Nasal mucociliary clearance time was prolonged in COVID-19 patients compared to healthy controls. Thus, we conclude that smell and taste are crucial symptoms that should not be overlooked in patients suspected of COVID-19 disease.

Keywords: COVID-19; Mucociliary clearance; Nasal disorders; Smell disorders.

MeSH terms

  • Adult
  • COVID-19*
  • Cross-Sectional Studies
  • Female
  • Humans
  • Male
  • Mucociliary Clearance*
  • Nasal Mucosa
  • Pandemics
  • SARS-CoV-2